Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/17227
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSafadi M.A.
dc.contributor.authorRiera-Montes M.
dc.contributor.authorBravo L.
dc.contributor.authorTangsathapornpong A.
dc.contributor.authorLagos R.
dc.contributor.authorThisyakorn U.
dc.contributor.authorLinhares A.C.
dc.contributor.authorCapeding R.
dc.contributor.authorPrommalikit O.
dc.contributor.authorVerstraeten T.
dc.contributor.authorO'Ryan M.
dc.date.accessioned2022-03-10T13:16:38Z-
dc.date.available2022-03-10T13:16:38Z-
dc.date.issued2021
dc.identifier.issn12019712
dc.identifier.other2-s2.0-85110538928
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/17227-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85110538928&doi=10.1016%2fj.ijid.2021.06.037&partnerID=40&md5=1eef88423a611972c45696414f28644e
dc.description.abstractBackground: Noroviruses (NoVs) cause acute gastroenteritis (AGE) worldwide, affecting children in particular. We aimed to estimate the burden of disease due to NoV among children aged <6 years in Brazil, Chile, Philippines and Thailand. Methods: This was a prospective, hospital-based, observational study. Children were recruited over one year between 2014 and 2017. Four cohorts were analysed: community-acquired AGE outpatients and inpatients, nosocomial AGE inpatients, and asymptomatic outpatients. We collected demographic and clinical data, and a stool sample that was tested for NoV. Positive samples were tested for Rotavirus (RV) and NoV-genotyped. Disease severity was assessed by the Vesikari and modified Vesikari scores. Prevalence and incidence of NoV-AGE were estimated by cohort and country. Results: 1637 participants yielded valid laboratory results. The proportion of NoV-positive cases was 23.8% (95% CI 20.8-27.2) in the outpatient cohort, 17.9% (15.0-21.3) in the hospital cohort, 21.4% (12.7-33.8) in the nosocomial cohort and 9.6% (6.9-13.2) in the asymptomatic cohort. Genotype GII.4 was predominant (58%). Less than 4% samples had RV coinfection. In general, NoV-positive subjects had more severe presentations than NoV-negative subjects. Conclusions: NoV caused AGE with substantial burden throughout the studied settings, with higher relative frequency in Brazil where RV vaccination coverage is high. © 2021 The Authors
dc.languageen
dc.subjectacute gastroenteritis
dc.subjectArticle
dc.subjectasymptomatic infection
dc.subjectBrazil
dc.subjectchild
dc.subjectChile
dc.subjectclinical feature
dc.subjectcohort analysis
dc.subjectcoinfection
dc.subjectcommunity acquired infection
dc.subjectdisease burden
dc.subjectdisease severity assessment
dc.subjectfemale
dc.subjectglobal disease burden
dc.subjecthospital infection
dc.subjecthospital patient
dc.subjecthuman
dc.subjectincidence
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectmolecular epidemiology
dc.subjectnonhuman
dc.subjectNorovirus
dc.subjectNorovirus genotype GII.4
dc.subjectnorovirus infection
dc.subjectobservational study
dc.subjectoutpatient
dc.subjectPhilippines
dc.subjectprevalence
dc.subjectprospective study
dc.subjectRotavirus infection
dc.subjectThailand
dc.subjectcalicivirus infection
dc.subjectfeces
dc.subjectgenetics
dc.subjectgenotype
dc.subjectinfant
dc.subjectNorovirus
dc.subjectvirus RNA
dc.subjectBrazil
dc.subjectCaliciviridae Infections
dc.subjectChild
dc.subjectChile
dc.subjectFeces
dc.subjectGenotype
dc.subjectHumans
dc.subjectInfant
dc.subjectNorovirus
dc.subjectPhilippines
dc.subjectProspective Studies
dc.subjectRNA, Viral
dc.subjectThailand
dc.titleThe burden of norovirus disease in children: a multi-country study in Chile, Brazil, Thailand and the Philippines
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationInternational Journal of Infectious Diseases. Vol 109, No. (2021), p.77-84
dc.identifier.doi10.1016/j.ijid.2021.06.037
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.